CRBP
Corbus Pharmaceuticals Holdings, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Corbus Pharmaceuticals Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Cormorant Asset ManagementCormorant | $22.0M | 15.14% | 0.00% | |
| 2 | Orbimed AdvisorsOrbimed | $16.3M | 11.22% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $12.5M | 8.59% | +390.04% | |
| 4 | Standard Life AberdeenStandard Life Aberdeen | $12.4M | 8.53% | 0.00% | |
| 5 | Diadema PartnersDiadema Partners | $8.8M | 6.04% | +68.40% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $7.1M | 4.91% | +3.66% | |
| 7 | Jones Hill CapitalJones Hill Capital | $6.1M | 4.22% | new | |
| 8 | Prosight ManagementProsight | $6.1M | 4.20% | −6.76% | |
| 9 | Caption ManagementCaption | $5.6M | 3.87% | +9175.92% | |
| 10 | Susquehanna International GroupSusquehanna International | $5.5M | 3.79% | +40.49% | |
| 11 | ADAR1 Capital ManagementADAR1 | $4.5M | 3.11% | +31.36% | |
| 12 | Stonepine Capital ManagementStonepine | $4.0M | 2.74% | +10.83% | |
| 13 | Geode Capital ManagementGeodeindex-like | $4.0M | 2.73% | +126.37% | |
| 14 | State StreetState Streetindex-like | $2.4M | 1.64% | +269.78% | |
| 15 | Citadel AdvisorsCitadel | $2.1M | 1.45% | −72.13% | |
| 16 | Dimensional Fund AdvisorsDimensional | $1.8M | 1.23% | +39.25% | |
| 17 | Exome Asset ManagementExome | $1.7M | 1.19% | −21.02% | |
| 18 | Jane Street GroupJane Street | $1.6M | 1.10% | +67.33% | |
| 19 | Mirae Asset Global Etfs HoldingsMirae Asset Global Etfs | $1.4M | 0.98% | −5.50% | |
| 20 | Northern TrustNorthern Trustindex-like | $1.2M | 0.81% | +200.95% | |
| 21 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $1.1M | 0.73% | new | |
| 22 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.0M | 0.72% | +356.81% | |
| 23 | Renaissance TechnologiesRenaissance Technologies | $1.0M | 0.72% | −68.06% | |
| 24 | DAFNA Capital ManagementDAFNA | $1.0M | 0.70% | new | |
| 25 | Advisory Services NetworkAdvisory Services Network | $843,740 | 0.58% | +642407.14% |
107 managers report $145.3M of Corbus Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; Cormorant is largest at 15.14%.
Corbus Pharmaceuticals Holdings, Inc.
4.20
−0.02 · −0.43%
post 4.20 +0.01%
No implied move.
No implied move.
Expected move
No implied move.